Apellis Pharmaceuticals Inc (APLS) Insider Trading
- $23,844,337.28
- $115,465,360.36
- Sept. 2, 2025
- Cedric Francois
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 16, 2020 | CEO | 5,000 | $39.38 | Sell | $196,900.00 | |
| Nov. 2, 2020 | Insider | 600 | $31.09 | Sell | $18,654.00 | |
| Oct. 15, 2020 | Director | 2,500 | $35.00 | Sell | $87,500.00 | |
| Oct. 15, 2020 | CEO | 5,000 | $34.46 | Sell | $172,300.00 | |
| Oct. 7, 2020 | Director | 7,500 | $35.00 | Sell | $262,500.00 | |
| Oct. 7, 2020 | Insider | 12,000 | $35.00 | Sell | $420,000.00 | |
| Sept. 15, 2020 | CEO | 5,000 | $30.96 | Sell | $154,800.00 | |
| Sept. 1, 2020 | Insider | 600 | $31.58 | Sell | $18,948.00 | |
| Aug. 20, 2020 | CEO | 3,457 | $30.00 | Sell | $103,710.00 | |
| Aug. 18, 2020 | CEO | 1,543 | $30.00 | Sell | $46,290.00 | |
| Aug. 3, 2020 | Insider | 600 | $26.28 | Sell | $15,768.00 | |
| July 15, 2020 | CEO | 5,000 | $32.12 | Sell | $160,600.00 | |
| July 1, 2020 | Insider | 850 | $32.43 | Sell | $27,565.50 | |
| June 15, 2020 | Director | 2,500 | $30.21 | Sell | $75,525.00 | |
| June 15, 2020 | CEO | 5,000 | $30.21 | Sell | $151,050.00 | |
| Nov. 15, 2019 | CEO | 5,000 | $27.82 | Sell | $139,100.00 | |
| Oct. 15, 2019 | CEO | 5,000 | $27.81 | Sell | $139,050.00 | |
| Sept. 24, 2019 | COO | 42,460 | $24.82 | Sell | $1,053,857.20 | |
| Sept. 16, 2019 | CEO | 5,000 | $26.59 | Sell | $132,950.00 | |
| Aug. 29, 2019 | CFO | 11,699 | $29.71 | Buy | $347,577.29 | |
| Aug. 15, 2019 | CEO | 10,000 | $26.80 | Sell | $268,000.00 | |
| March 11, 2019 | Major Shareholder | 441,176 | $17.00 | Buy | $7,499,992.00 | |
| Sept. 21, 2018 | Major Shareholder | 81,323 | $19.48 | Buy | $1,584,172.04 | |
| Sept. 19, 2018 | Major Shareholder | 140,000 | $18.34 | Buy | $2,567,600.00 | |
| Sept. 14, 2018 | General Counsel | 15,776 | $18.78 | Sell | $296,273.28 | |
| May 24, 2018 | Insider | 2,935 | $20.37 | Buy | $59,785.95 | |
| Nov. 13, 2017 | Major Shareholder | 127,515 | $14.00 | Buy | $1,785,210.00 |
Insiders are both buying and selling Apellis Pharmaceuticals Inc stock.
The insider traders at Apellis Pharmaceuticals Inc are: Cedric Francois, Alec Machiels, Federico Grossi, Pascal Deschatelets, David O Watson, A. Sinclair Dunlop, Mark Jeffrey Delong, Timothy Eugene Sullivan, James George Chopas, Adam J Townsend, Lukas Scheibler, Jeffrey Eisele, Nur Nicholson, Nicole D Perry, Morningside Venture Investment, Karen Lewis, Caroline Baumal, Machiels Alec, Global Strategic Fund I Venbio, Deschatelets Pascal, Victoria L Brown, and Victoria L. Brown
The most active insider trader at Apellis Pharmaceuticals Inc is Cedric Francois with 32 trades.
Cedric Francois has sold the most Apellis Pharmaceuticals Inc stock with a total value of $46,527,040.87.
Morningside Venture Investment has bought the most Apellis Pharmaceuticals Inc stock with a total value of $31,651,764.04.
The most recent insider trade for Apellis Pharmaceuticals Inc was on Sept. 2, 2025.
The single biggest insider buy for Apellis Pharmaceuticals Inc was from Morningside Venture Investment with a total value of $10,000,000.00 on Nov. 18, 2021.
The single biggest insider sell for Apellis Pharmaceuticals Inc was from Cedric Francois with a total value of $16,027,500.00 on March 1, 2024.